Schwartz Center Rounds, “Passing on biases and assumptions”

Register in advance for this webinar:

www.unccn.org/schwartzrounds

After registering, you will receive a confirmation email containing information about joining the webinar.

For information on how to attend a Zoom Webinar, please see: https://support.zoom.us/hc/en-us/articles/115004954946-Joining-a-Webinar-Attendee-

Activity Director: Frances Collichio, MD

Facilitator: Theresa Raphael-Grimm, PhD

Description: Schwartz Center Rounds is a multi-disciplinary forum for open discussion of psycho-social aspects of patient care. The primary purpose is to facilitate dialog among health care professionals around challenging care-based issues. The goal of Schwartz is to foster communication, understanding, and knowledge development in the quest to promote compassionate patient care and compassionate understanding among and between clinicians.

* Lunch is provided. Please arrive early to obtain lunch and a beverage before being seated.

The following organizations are generously providing funding to the Schwartz Center to support the Schwartz Center Rounds^®: Amgen Foundation; Millennium – The Takeda Oncology Company: The Yawkey Foundation

These organizations have no control or influence over the content of the Schwartz Center Rounds.

Disclaimer: None of these funds go to the UNC Schwartz Rounds

Accreditation statement:

The School of Medicine of The University of North Carolina at Chapel Hill is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians

Credit statement:

The School of Medicine of The University of North Carolina at Chapel Hill designates this live activity for a maximum of 1.0 “MA PRA Category 1 Credit(s)™”. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure statement:

Moderator Disclosure: Dr. Collichio receives consulting fees from Amgen and research support from Amgen, Bristol Myers Squibb, Morphotek, and Novartis (GSK). Dr. Raphael-Grimm has no financial relationships with commercial interests.